AKR1E2 Antibody
-
中文名稱：AKR1E2兔多克隆抗體
-
貨號：CSB-PA001547GA01HU
-
規格：￥3,900
-
其他：
產品詳情
-
Uniprot No.：
-
基因名：AKR1E2
-
別名：AKR1E2 antibody; AKR1CL2 antibody; AKRDC11,5-anhydro-D-fructose reductase antibody; AF reductase antibody; EC 1.1.1.263 antibody; Aldo-keto reductase family 1 member C-like protein 2 antibody; Aldo-keto reductase family 1 member E2 antibody; LoopADR antibody; Testis aldo-keto reductase antibody; htAKR antibody; Testis-specific protein antibody; hTSP antibody
-
宿主：Rabbit
-
反應種屬：Human,Mouse,Rat
-
免疫原：Human AKR1CL2
-
免疫原種屬：Homo sapiens (Human)
-
抗體亞型：IgG
-
純化方式：Antigen Affinity purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
-
產品提供形式：Liquid
-
應用范圍：ELISA,WB,IF
-
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Catalyzes the NADPH-dependent reduction of 1,5-anhydro-D-fructose (AF) to 1,5-anhydro-D-glucitol. Has low NADPH-dependent reductase activity towards 9,10-phenanthrenequinone (in vitro).
-
基因功能參考文獻：
- results indicate that the expression of human testis aldo-keto reductase, down-regulated in the testicular tumour, is possibly controlled by mitogenic and hormonal signals PMID: 15118078
-
亞細胞定位：Cytoplasm.
-
蛋白家族：Aldo/keto reductase family
-
組織特異性：Specifically expressed in testis. Expressed in testicular germ cells and testis interstitial cells.
-
數據庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
